Science
Trump Administration Slashes Research Into L.G.B.T.Q. Health

The Trump administration has scrapped more than $800 million worth of research into the health of L.G.B.T.Q. people, abandoning studies of cancers and viruses that tend to affect members of sexual minority groups and setting back efforts to defeat a resurgence of sexually transmitted infections, according to an analysis of federal data by The New York Times.
In keeping with its deep opposition to both diversity programs and gender-affirming care for adolescents, the administration has worked aggressively to root out research touching on equity measures and transgender health.
But its crackdown has reverberated far beyond those issues, eliminating swaths of medical research on diseases that disproportionately afflict L.G.B.T.Q. people, a group that comprises nearly 10 percent of American adults.
Of the 669 grants that the National Institutes of Health had canceled in whole or in part as of early May, at least 323 — nearly half of them — related to L.G.B.T.Q. health, according to a review by The Times of every terminated grant.
Federal officials had earmarked $806 million for the canceled projects, many of which had been expected to draw more funding in the years to come.
Scores of research institutions lost funding, a list that includes not only White House targets like Johns Hopkins and Columbia, but also public universities in the South and the Midwest, like Ohio State University and the University of Alabama at Birmingham.
At Florida State University, $41 million worth of research was canceled, including a major effort to prevent H.I.V. in adolescents and young adults, who experience a fifth of new infections in the United States each year.
In termination letters over the last two months, the N.I.H. justified the cuts by telling scientists that their L.G.B.T.Q. work “no longer effectuates agency priorities.” In some cases, the agency said canceled research had been “based on gender identity,” which gave rise to “unscientific” results that ignored “biological realities.”
Other termination letters told scientists their studies erred by being “based primarily on artificial and nonscientific categories, including amorphous equity objectives.”
The cuts follow a surge in federal funding for L.G.B.T.Q. research over the past decade, and active encouragement from the N.I.H. for grant proposals focused on sexual and gender minority groups that began during the Obama administration.
President Trump’s allies have argued that the research is shot through with ideological bias.
“There’s been a train of abuses of the science to fit a preconceived conclusion,” said Roger Severino of the Heritage Foundation, the conservative think tank that helped formulate some Trump administration policies.
“And that was based on an unscientific premise that biology is effectively irrelevant, and a political project of trying to mainstream the notion that people could change their sex.”
Scientists said canceling research on such a broad range of illnesses related to sexual and gender minority groups effectively created a hierarchy of patients, some more worthy than others.
“Certain people in the United States shouldn’t be getting treated as second-class research subjects,” said Simon Rosser, a professor at the University of Minnesota whose lab was studying cancer in L.G.B.T.Q. people before significant funding was pulled.
“That, I think, is anyone’s definition of bigotry,” he added. “Bigotry in science.”
The canceled projects are among the most vivid manifestations of a broad dismantling of the infrastructure that has for 80 years supported medical research across the United States.
Beyond terminating studies, federal officials have gummed up the grant-making process by slow-walking payments, delaying grant review meetings and scaling back new grant awards.
Bigger changes may be in store: Mr. Trump on Friday proposed reducing the N.I.H. budget from roughly $48 billion to $27 billion, citing in part what he described as the agency’s efforts to promote “radical gender ideology.”
The legality of the mass terminations is unclear. Two separate lawsuits challenging the revocation of a wide range of grants — one filed by a group of researchers, and the other by 16 states — argued that the Trump administration had failed to offer a legal rationale for the cuts.
The White House and the Department of Health and Human Services did not respond to requests for comment.
Andrew Nixon, a spokesman for the health department, told The Daily Signal, a conservative publication, last month that the move “away from politicized D.E.I. and gender ideology studies” was in “accordance with the president’s executive orders.”
The N.I.H. said in a statement: “N.I.H. is taking action to terminate research funding that is not aligned with N.I.H. and H.H.S. priorities. We remain dedicated to restoring our agency to its tradition of upholding gold-standard, evidence-based science.”
The L.G.B.T.Q. cuts ended studies on antibiotic resistance, undiagnosed autism in sexual minority groups, and certain throat and other cancers that disproportionately affect those groups. Funding losses have led to firings at some L.G.B.T.Q.-focused labs that had only recently been preparing to expand.
The N.I.H. used to reserve grant cancellations for rare cases of research misconduct or possible harm to participants. The latest cuts, far from protecting research participants, are instead putting them in harm’s way, scientists said.
They cited the jettisoning of clinical trials, which have now been left without federal funding to care for volunteer participants.
“We’re stopping things that are preventing suicide and preventing sexual violence,” said Katie Edwards, a professor at the University of Michigan, whose funding for several clinical trials involving L.G.B.T.Q. people was canceled.
H.I.V. research has been hit particularly hard.
The N.I.H. ended several major grants to the Adolescent Medicine Trials Network for H.I.V./AIDS Intervention, a program that had helped lay the groundwork for the use in adolescents of a medication regimen that can prevent infections.
That regimen, known as pre-exposure prophylaxis, or PrEP, is credited with helping beat back the disease in young people.
Cuts to the program have endangered an ongoing trial of a product that would prevent both H.I.V. and pregnancy and a second trial looking at combining sexual health counseling with behavioral therapy to reduce the spread of H.I.V. in young sexual minority men who use stimulants.
Together with the termination of dozens of other H.I.V. studies, the cuts have undermined Mr. Trump’s stated goal from his first term to end the country’s H.I.V. epidemic within a decade, scientists said.
The N.I.H. terminated work on other sexually transmitted illnesses, as well.
Dr. Matthew Spinelli, an infectious disease researcher at the University of California, San Francisco, was in the middle of a clinical trial of doxycycline, a common antibiotic that, taken after sex, can prevent some infections with syphilis, gonorrhea and chlamydia.
The trial was, he said, “as nerdy as it gets”: a randomized study in which participants were given different regimens of the antibiotic to see how it is metabolized.
He hoped the findings would help scientists understand the drug’s effectiveness in women, and also its potential to cause drug resistance, a concern that Secretary of State Marco Rubio had voiced in the past.
But health officials, citing their opposition to research regarding “gender identity,” halted funding for the experiment in March. That left Dr. Spinelli without any federal funding to monitor the half-dozen people who had already been taking the antibiotic.
It also put the thousands of doses that Dr. Spinelli had bought with taxpayer money at risk of going to waste. He said stopping work on diseases like syphilis and H.I.V. would allow new outbreaks to spread.
“The H.I.V. epidemic is going to explode again as a result of these actions,” said Dr. Spinelli, who added that he was speaking only for himself, not his university. “It’s devastating for the communities affected.”
Despite a recent emphasis on the downsides of transitioning, federal officials canceled several grants examining the potential risks of gender-affirming hormone therapy. The projects looked at whether hormone therapy could, for example, increase the risk of breast cancer, cardiovascular disease, altered brain development or H.I.V.
Other terminated grants examined ways of addressing mental illness in transgender people, who now make up about 3 percent of high school students and report sharply higher rates of persistent sadness and suicide attempts.
For Dr. Edwards, of the University of Michigan, funding was halted for a clinical trial looking at how online mentoring might reduce depression and self-harm among transgender teens, one of six studies of hers that were canceled.
Another examined interventions for the families of L.G.B.T.Q. young people to promote more supportive caregiving and, in turn, reduce dating violence and alcohol use among the young people.
The N.I.H. categorizes research only by certain diseases, making it difficult to know how much money the agency devotes to L.G.B.T.Q. health. But a report in March estimated that such research made up less than 1 percent of the N.I.H. portfolio over a decade.
The Times sought to understand the scale of terminated funding for L.G.B.T.Q. medical research by reviewing the titles and, in many cases, research summaries for each of the 669 grants that the Trump administration said it had canceled in whole or in part as of early May.
Beyond grants related to L.G.B.T.Q. people and the diseases and treatments that take a disproportionate toll on them, The Times included in its count studies that were designed to recruit participants from sexual and gender minority groups.
It excluded grants related to illnesses like H.I.V. that were focused on non-L.G.B.T.Q. patients.
While The Times examined only N.I.H. research grants, the Trump administration is also ending or considering ending L.G.B.T.Q. programs elsewhere in the federal health system. It has proposed, for example, scrapping a specialized suicide hotline for L.G.B.T.Q. young people.
The research cuts stand to hollow out a field that in the last decade had not only grown larger, but also come to encompass a wider range of disease threats beyond H.I.V.
Already, scientists said, younger researchers are losing jobs in sexual and gender minority research and scrubbing their online biographies of evidence that they ever worked in the field.
Five grants obtained by Brittany Charlton, a professor at the Harvard School of Public Health, have been canceled, including one looking at sharply elevated rates of stillbirths among L.G.B.T.Q. women.
Ending research on disease threats to gender and sexual minority groups, she said, would inevitably rebound on the entire population. “When other people are sick around you, it does impact you, even if you may think it doesn’t,” she said.
Irena Hwang contributed reporting.

Science
Video: SpaceX Rocket Launches Carrying 3 Weather-Monitoring Spacecraft

new video loaded: SpaceX Rocket Launches Carrying 3 Weather-Monitoring Spacecraft
transcript
transcript
SpaceX Rocket Launches Carrying 3 Weather-Monitoring Spacecraft
Two of the spacecraft are for NASA and one is for the National Oceanic and Atmospheric Administration.
-
“Three, two, one — engines full power and liftoff. Go, Falcon. Go IMAP. Go SWFO-L1 and go Carruthers.” “And we are flying three new missions on a million-mile journey to track space weather.”
Science
RFK Jr. wants an answer to rising autism rates. Scientists say he’s ignoring some obvious ones

This week, the Trump administration announced that it was taking “bold action” to address the “epidemic” of autism spectrum disorder — starting with a new safety label on Tylenol and other acetaminophen products that suggests a link to autism. The scientific evidence for doing so is weak, researchers said.
Health and Human Services Secretary Robert F. Kennedy Jr. said federal officials “will be uncompromising and relentless in our search for answers” and that they soon would be “closely examining” the role of vaccines, whose alleged link to autism has been widely discredited.
Kennedy has long argued that rising diagnoses among U.S. children must mean more exposure to some outside influence: a drug, a chemical, a toxin, a vaccine.
“One of the things that I think that we need to move away from today is this ideology that … the autism prevalence increase, the relentless increases, are simply artifacts of better diagnoses, better recognition or changing diagnostic criteria,” Kennedy said in April.
Kennedy is correct that autism spectrum disorder rates have risen steadily in the U.S. since the U.S. Centers for Disease Control began tracking them, from 1 in 150 8-year-olds in 2000, to 1 in 31 in 2022, the most recent year for which numbers are available.
But physicians, researchers and psychologists say it is impossible to interpret this increase without acknowledging two essential facts: The diagnostic definition of autism has greatly expanded to include a much broader range of human behaviors, and we look for it more often than we used to.
“People haven’t changed that much,” said Alan Gerber, a pediatric neuropsychologist at Children’s National Hospital in Washington, D.C., “but how we talk about them, how we describe them, how we categorize them has actually changed a lot over the years.”
Defining ‘autism’
The term “autism” first appeared in the scientific literature around World War II, when two psychiatrists in different countries independently chose that word to describe two different groups of children.
In 1938, Austrian pediatrician Hans Asperger used it to describe child patients at his Vienna clinic who were verbal, often fluently so, with unusual social behaviors and at-times obsessive focus on very specific subjects.
Five years later, U.S. psychiatrist Leo Kanner published a paper about a group of children at his clinic at the Johns Hopkins Hospital in Baltimore who were socially withdrawn, rigid in their thinking and extremely sensitive to stimuli like bright lights or loud noises. Most also had limited verbal language ability.
Both Asperger and Kanner chose the same word to describe these overlapping behaviors: autism. (They borrowed the term from an earlier psychiatrist’s description of extreme social withdrawal in schizophrenic patients.)
This doesn’t mean children never acted this way before. It was just the first time doctors started using that word to describe a particular set of child behaviors.
For the next few decades, many children who exhibited what we understand today to be autistic traits were labeled as having conditions that have ceased to exist as formal diagnoses, like “mental retardation,” “childhood psychosis” or “schizophrenia, childhood type.”
Autism debuted as its own diagnosis in the 1980 third edition of the Diagnostic and Statistical Manual of Mental Disorders, the American Psychiatric Assn.’s diagnostic bible. It described an autistic child as one who, by the age of 2½, showed impaired communication, unusual responses to their environment and a lack of interest in other people.
As the decades went on, the DSM definition of autism broadened.
The fourth edition, published in 1994, named additional behaviors: impaired relationships, struggles with nonverbal communication and speech patterns different from those of non-autistic, or neurotypical, peers.
It also included a typo that would turn out to be a crucial driver of diagnoses, wrote cultural anthropologist Roy Richard Grinker in his book “Unstrange Minds: Remapping the World of Autism.”
The DSM’s printed definition of autism included any child who displayed impairments in social interaction, communication “or” behavior. It was supposed to say social interaction, communication “and” behavior.
The error went uncorrected for six years, and the impact appeared profound. In 1995 an estimated 1 in every 500 children was diagnosed with autism. By 2000, when the CDC formally began tracking diagnoses (and the text was corrected), it was 1 in every 150.
Reaching underserved communities
In 2007, the American Academy of Pediatrics recommended for the first time that all children be screened for autism between the ages of 18 and 24 months as part of their regular checkups. Prior to that, autism was diagnosed somewhat haphazardly. Not all pediatricians were familiar with the earliest indicators or used the same criteria to determine whether a child should be further evaluated.
Then in 2013, the fifth edition of the DSM took what had previously been four separate conditions — autistic disorder, Asperger’s disorder, childhood disintegrative disorder and pervasive developmental disorder — and collapsed them all into a single diagnosis: autism spectrum disorder.
The diagnostic criteria for ASD included a broad range of social, communication and sensory interpretation differences that, crucially, could be identified at any time in a child’s life. The term was no longer limited only to children whose development lagged noticeably behind that of their peers.
Since that definition was adopted, U.S. schools have become more proactive about referring a greater range of children for neurodevelopmental evaluations. The new DSM language also helped educators and clinicians better understand what was keeping some kids in disadvantaged communities from thriving.
“In the past, [autism was] referred to as a ‘white child’s disability,’ because you found so few Black and brown children being identified,” said Shanter Alexander, an assistant professor of school psychology at Howard University. Children of color who struggled with things like behavioral disruptions, attention deficits or language delays, she said, were often diagnosed with intellectual disabilities or behavioral disorders.
In a sign that things have shifted, the most recent CDC survey for the first time found a higher prevalence of autism in kids of color than in white children: 3.66%, 3.82% and 3.30% for Black, Asian and Latino children, respectively, compared with 2.77% of white children.
“A lot of people think, ‘Oh, no, what does this mean? This is terrible.’ But it’s actually really positive. It means that we have been better at diagnosing Latino children [and] other groups too,” said Kristina Lopez, an associate professor at Arizona State University who studies autism in underserved communities.
The severity issue
An autism diagnosis today can apply to people who are able to graduate from college, hold professional positions and speak eloquently about their autism, as well as people who require 24-hour care and are not able to speak at all.
It includes people who were diagnosed when they were toddlers developing at a noticeably different pace from their peers, and people who embraced a diagnosis of autism in adulthood as the best description of how they relate to the world. Diagnoses for U.S. adults ages 26 to 34 alone increased by 450% between 2011 and 2022, according to one large study published last year in the Journal of the American Medical Assn.
Kennedy was not correct when he said in April that “most cases now are severe.”
A 2016 review of CDC data found that approximately 26.7% of 8-year-olds with autism had what some advocates refer to as “profound autism,” the end of the spectrum that often includes seriously disabling behaviors such as seizures, self-injurious behavior and intellectual disability.
The rate of children with profound autism has remained virtually unchanged since the CDC started tracking it, said Maureen Durkin, a professor of population health science and pediatrics at the University of Wisconsin-Madison. Indeed, the highest rate of new diagnoses has been among children with mild limitations, she said.
For many researchers and advocates, the Trump administration’s focus on autism has provoked mixed emotions. Many have lobbied for years for more attention for this condition and the people whose lives it affects.
Now it has arrived, thanks to an administration that has played up false information while cutting support for science.
“They have attempted to panic the public with the notion of an autism epidemic as a threat to the nation, when no such epidemic actually exists — rather, more people are being diagnosed with autism today because we have broader diagnostic criteria and do a better job detecting it,” said Colin Killick, executive director of the Autistic Self Advocacy Network. “It is high time that this administration stops spreading misinformation about autism, and starts enacting policies that would actually benefit our community.”
This article was reported with the support of the USC Annenberg Center for Health Journalism’s National Fellowship’s Kristy Hammam Fund for Health Journalism.
Science
Forest Service reverses decades-long ban, allows wildfire firefighters to use N95 masks

The U.S. Forest Service has announced it is reversing a ban on federal firefighters wearing masks, and will give crews protective N95s as they battle increasingly intense fires across the nation.
For decades, the agency argued their use made firefighters vulnerable to heat exhaustion.
Other wildfire-prone nations, such as Canada, Greece and Australia, provide their firefighters with masks to prevent lung damage and smoke-related diseases, including cancer and organ failure — and have not seen increases in heat stroke among the crews.
The policy will have little bearing on local and regional urban firefighters, such as those in Los Angeles and Los Angeles County.
“We are actually encouraged to wear them,” said Jonathan Torres, engineer and spokesman for the Los Angeles County Fire Department.
“There are chemicals that are unknown to us that are part of our work,” as buildings and infrastructure burn, he said. Masks provide some protection against harmful smoke particles and chemicals released when plastics, upholstery and synthetic building materials burn.
Earlier this week, the forest agency announced it has stockpiled roughly 80,000 N95 masks and will include them as part of the equipment they provide for large fires.
The decision came following a series of New York Times reports that detailed the Forest Service’s decades-long refusal to require, or even offer, masks to its crews, despite recommendations from state and federal health agencies, and a growing body of evidence that wildfire smoke is harming firefighter health.
“To provide masks, and even require masks, is an implicit admission of the health hazards of smoke,” said Timothy Ingalsbee, executive director of Firefighters United for Safety, Ethics and Ecology, an organization that promotes the health and safety of wildland firefighters.
Ingalsbee and others say the Forest Service’s reluctance to encourage mask wearing was probably motivated by concern it would be admitting that smoke poses dangers and risks to its crews.
Research shows that firefighters have a 9% higher risk of getting a cancer diagnosis than the general public, and 14% higher risk of dying from cancer. Crews may be exposed to smoke and other toxins believed to cause cancer, such as benzene, phenols and heavy metals, while fighting fires.
Federal lawmakers are now working on safety legislation to protect federal and contract wildland firefighters, and have sent a series of letters to the Forest Service criticizing what they call its decades-long neglect.
Reports suggest that “that federal agencies are neglecting their duty to protect the health of wildland firefighters,” wrote Reps. Jared Huffman (D-San Rafael), Maxine Dexter (D-Ore.) and Joe Neguse (D-Colo.) in a letter to Forest Service chief Tom Schultz. “Neglecting the health of current firefighters will make future recruitment harder and leave our communities vulnerable.”
On Tuesday, they grilled Schultz at a House oversight meeting.
Huffman urged Schultz to warn workers about the dangers of smoke exposure: “Chief, do you feel like the Forest Service is doing everything that it can to make the safety risk of smoke inhalation known to firefighters?”
Gov. Gavin Newsom and the California Department of Forestry and Fire Protection also announced Tuesday that the state will be funding research designed to examine how smoke and other occupational exposures may increase cancer risk in firefighters.
The research, which includes a collaboration among scientists and experts at UCLA, UC Davis and Cal Fire, is backed by nearly $9.7 million in state funding and will include 3,500 firefighters from departments across the state over a two-year period.
The study comes at a time when the Trump administration has made drastic cuts to cancer research.
“It’s California at our best: our world-class public universities teaming up with the women and men who put their lives on the line to protect others — all in an effort to improve health outcomes for all,” Newsom said in a statement.
The study will include a focus on the exposures and biological changes that occurred in firefighters who responded to the Eaton and Palisades fires in Los Angeles.
Ingalsbee said that masks are not always appropriate when fighting fires — there are activities, such as traipsing up and down steep terrain when a N95 mask can get gummed up with debris and sweat and make it difficult for a firefighter to breathe.
However, he said the vast majority of the time, when firefighters are at their base camps, where it’s often smoky, or driving along dusty, sandy roads, masks could go a long way to protect their lungs, reducing exposure.
“There are times when masks are unsuitable and firefighters overheat and they are uncomfortable,” he said. “But there’s a lot of times when they’d be very useful in limiting their exposure. And maybe could save some lives.”
-
Finance6 days ago
Reimagining Finance: Derek Kudsee on Coda’s AI-Powered Future
-
World1 week ago
Russian jets enter Estonia's airspace in latest test for NATO
-
North Dakota6 days ago
Board approves Brent Sanford as new ‘commissioner’ of North Dakota University System
-
World5 days ago
Syria’s new president takes center stage at UNGA as concerns linger over terrorist past
-
Technology5 days ago
These earbuds include a tiny wired microphone you can hold
-
Culture5 days ago
Test Your Memory of These Classic Books for Young Readers
-
Crypto5 days ago
Texas brothers charged in cryptocurrency kidnapping, robbery in MN
-
Crypto6 days ago
EU Enforcers Arrest 5 Over €100M Cryptocurrency Scam – Law360